advanced endometrial cancerchemoresistanceepothilonePTENType I endometrial carcinomaType II endometrial carcinomaEndometrial carcinoma is the most common gynecological malignancy. Prognosis is poor following disease recurrence or diagnosis at an advanced stage. In this setting, combination chemotherapy is the ...
cancer treatmenttarget‐based therapiesdifferentiation therapyarsenic trioxidelung cancerBetween 1984 and 1993 the deposition of As, Cr, Co and Ni with bulk precipitation was measured on 6 open field sites in Northrhine-Westphalia/Germany. The absolute amount of As, Cr, Co and Ni deposition varies...
A new form of cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy has plenty of promise but is not a silver bullet, according to Dr Lucas Chan, the Chief Scientific Officer at Stem Med, a company related to Parkway Cancer Centre. Dr Chan, who was involve...
to as the fourth major modality for cancer treatment [4]. As a constituent of cancer immunotherapy, cancer nanovaccines utilize nanocarriers to deliver vaccine payloads into the body, exhibiting excellent anti-tumor immune effects and greatly accelerating progress in tumor prevention and treatment [5...
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncol... This year, for the first time, the American Society of Clinical Oncology (ASCO) is publishing Clinical Cancer Advances 2005: Major Research...
Despite advances in the treatment of gastric cancer,it remains the world's second highest cause of cancer death.As gastric cancer is often diagnosed at an ... Ahmet,Bilici - 《世界胃肠病学杂志(英文版)》 被引量: 87发表: 2014年 Treatment options in patients with metastatic gastric cancer:Curr...
in the breakdown of normal regulatory systems. Nowadays, immunotherapy is a well-known treatment strategy for cancer that can enhance the existing anti-tumor response so that immune cells can restrict the growth of malignant cells. Again, immunotherapy can effectively target the cancer cells while ...
has ushered in a new era in cancer treatment. We have reason to believe that with the continuous development and maturation of nanotechnology, nanobodies will provide cancer patients with more precise and personalized treatment options, ultimately leading them to victory in the battle against cancer....
Since more comprehensive and profound insights about intratumoral microbiota are continuously emerging, new methods for the early diagnosis and prognostic assessment of cancer patients have been under examination. In addition, interventions based on intratumoural microbiota show great potential to open a ...